EZH2 and prostate carcinoma: Apparently, hypoxia induced the expression of the enhancer of zeste homolog 2 (EZH2), a histone methyltransferase, which in turn regulates the hypermethylation of the TGFBR2 promoter in a model of prostate cancer [80].